Best Hospitals for Rastelli Procedure in UAE

The total cost of the Rastelli Procedure in India — including surgery, cardiopulmonary bypass, valved conduit (homograft or Contegra), Pediatric Cardiac ICU stay (3–5 days), general ward stay, anesthesia, and standard post-operative medications — typically ranges from USD 8,000 to USD 16,000 at JCI and NABH-accredited centers. This represents a saving of 70–80% compared to equivalent procedures in the United States or United Kingdom (where costs routinely exceed USD 80,000–120,000). In the UAE, at JCI and DHA/DOH-accredited hospitals in Dubai and Abu Dhabi, the same procedure ranges from approximately USD 22,000 to USD 40,000, reflecting higher facility overheads, premium nursing ratios, and the regional infrastructure costs of a Gulf healthcare system. Both price ranges are estimates and can vary based on patient age, body weight, conduit selection (homografts are generally more expensive than xenograft conduits), complexity of associated lesions, duration of ICU stay, and whether re-operative surgery is involved. GAF Healthcare provides a detailed, itemized cost estimate based on each patient's specific diagnostic records before any commitment is made. Neither destination requires a deposit before the medical evaluation is complete.

Families should plan for a total in-country stay of 8 to 10 weeks following the Rastelli Procedure, though some patients may receive clearance for international air travel as early as 6 weeks post-operatively if recovery is uncomplicated. The key medical milestones that must be achieved before long-haul flight clearance are: complete sternal healing and stability (typically confirmed at 4–6 weeks), stable hemodynamics without inotropic or oxygen support, a resting oxygen saturation consistently above 94% on room air, no uncontrolled pleural or pericardial effusion, and a final outpatient echocardiogram demonstrating satisfactory conduit function and ventricular performance. The treating congenital cardiologist and surgeon jointly issue the fitness-to-fly certificate. For short-haul flights (under 3 hours), clearance may be possible at 5–6 weeks in select cases. Airlines require a medical clearance letter (MEDIF form) for patients who have undergone recent cardiac surgery; GAF Healthcare prepares this documentation in coordination with the surgical team. Families should not book return flights with fixed dates before receiving formal clearance, and should plan for travel insurance that covers medical extensions. GAF Healthcare's in-country coordinator assists with flight rebooking and accommodation extensions as needed.

At experienced, high-volume congenital cardiac centers — the type GAF Healthcare exclusively partners with in India and the UAE — the operative survival rate for the primary Rastelli Procedure is 92–97% (operative mortality of 3–8%), with outcomes closely correlated to surgical volume, institutional experience, and PCICU expertise. Long-term survival data from major series (including those published from centers such as the Mayo Clinic, Great Ormond Street Hospital, and equivalent high-volume Asian centers) show 10-year survival rates of approximately 85–90% and 20-year survival rates of 75–85%, with the primary cause of late mortality being conduit-related reinterventions and ventricular dysfunction rather than the index repair itself. The most important long-term consideration is conduit durability: virtually all patients will require conduit reintervention within 10–20 years, either via surgical conduit replacement or transcatheter pulmonary valve replacement (TPVR) using the Melody or SAPIEN 3 valve — a now well-established, minimally invasive catheter-based procedure. Freedom from any reintervention at 10 years is approximately 50–65%, while freedom from death or serious cardiac event at 10 years exceeds 80% at specialized centers. Quality of life outcomes are generally favorable: the majority of Rastelli patients reach adulthood with good functional capacity (NYHA Class I or II), can attend school normally, and participate in moderate physical activity, though lifelong cardiology surveillance with periodic cardiac MRI and catheterization is mandatory. GAF Healthcare provides patients with a structured long-term follow-up plan and telemedicine access to the treating cardiologist for ongoing remote surveillance after returning home.